• / Free eNewsletters & Magazine
  • / My Account
Home>Companies>King Pharmaceuticals

King Pharmaceuticals

  1. Prozac Nation, Street Version

    Allscripts MDRX reported first-quarter results that were within the range of our expectations. We are maintaining our fair value estimate. The company generated $65 million in revenue, a 54% increase from the year-ago period. The strong revenue growth was propelled by an 81% revenue increase in the ...

  2. Stock Star Rating Performance Update

    As 2005 draws to a close, our performance continues to be solid all around, with some bright spots and a few areas for further improvement. Our contrarian stance on large-cap and energy stocks has weighed on our results recently, but we're still confident that those calls will work out in the end. ...

Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.